Anuj B Mehta1, Sohera N Syeda2, Renda Soylemez Wiener3, Allan J Walkey4. 1. The Pulmonary Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA. Electronic address: anuj.mehta2@bmc.org. 2. The Pulmonary Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA; VA Boston Healthcare System, Boston, MA. 3. The Pulmonary Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA; Center for Healthcare Organization & Implementation Research, Edith Nourse Rogers Memorial VA Hospital, Bedford, MA. 4. The Pulmonary Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA.
Abstract
PURPOSE: Epidemiological trends for invasive mechanical ventilation (IMV) have not been clearly defined. We sought to define trends for IMV in the United States and assess for disease-specific variation for 3 common causes of respiratory failure: pneumonia, heart failure (HF), and chronic obstructive pulmonary disease (COPD). METHODS: We calculated national estimates for utilization of nonsurgical IMV cases from the Nationwide Inpatient Sample from 1993 to 2009 and compared trends for COPD, HF, and pneumonia. RESULTS: We identified 8309344 cases of IMV from 1993 to 2009. Utilization of IMV for nonsurgical indications increased from 178.9 per 100000 in 1993 to 310.9 per 100000 US adults in 2009. Pneumonia cases requiring IMV showed the largest increase (103.6%), whereas COPD cases remained relatively stable (2.5% increase) and HF cases decreased by 55.4%. Similar demographic and clinical changes were observed for pneumonia, COPD, and HF, with cases of IMV becoming younger, more ethnically diverse, and more frequently insured by Medicaid. Outcome trends for patients differed based on diagnosis. Adjusted hospital mortality decreased over time for cases of pneumonia (odds ratio [OR] per 5 years, 0.89; 95% confidence interval [CI], 0.88-0.90) and COPD (OR per 5 years, 0.97; 95% CI, 0.97-0.98) but increased for HF (OR per 5 years, 1.10; 95% CI, 1.09-1.12). CONCLUSION: Utilization of IMV in the US increased from 1993 to 2009 with a decrease in overall mortality. However, trends in utilization and outcomes of IMV differed markedly based on diagnosis. Unlike favorable outcome trends in pneumonia and COPD, hospital mortality for HF has not improved. Further studies to investigate the outcome gap between HF and other causes of respiratory failure are needed.
PURPOSE: Epidemiological trends for invasive mechanical ventilation (IMV) have not been clearly defined. We sought to define trends for IMV in the United States and assess for disease-specific variation for 3 common causes of respiratory failure: pneumonia, heart failure (HF), and chronic obstructive pulmonary disease (COPD). METHODS: We calculated national estimates for utilization of nonsurgical IMV cases from the Nationwide Inpatient Sample from 1993 to 2009 and compared trends for COPD, HF, and pneumonia. RESULTS: We identified 8309344 cases of IMV from 1993 to 2009. Utilization of IMV for nonsurgical indications increased from 178.9 per 100000 in 1993 to 310.9 per 100000 US adults in 2009. Pneumonia cases requiring IMV showed the largest increase (103.6%), whereas COPD cases remained relatively stable (2.5% increase) and HF cases decreased by 55.4%. Similar demographic and clinical changes were observed for pneumonia, COPD, and HF, with cases of IMV becoming younger, more ethnically diverse, and more frequently insured by Medicaid. Outcome trends for patients differed based on diagnosis. Adjusted hospital mortality decreased over time for cases of pneumonia (odds ratio [OR] per 5 years, 0.89; 95% confidence interval [CI], 0.88-0.90) and COPD (OR per 5 years, 0.97; 95% CI, 0.97-0.98) but increased for HF (OR per 5 years, 1.10; 95% CI, 1.09-1.12). CONCLUSION: Utilization of IMV in the US increased from 1993 to 2009 with a decrease in overall mortality. However, trends in utilization and outcomes of IMV differed markedly based on diagnosis. Unlike favorable outcome trends in pneumonia and COPD, hospital mortality for HF has not improved. Further studies to investigate the outcome gap between HF and other causes of respiratory failure are needed.
Authors: Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz Journal: Pharmacoepidemiol Drug Saf Date: 2012-01 Impact factor: 2.890
Authors: M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald Journal: Lancet Date: 2000-05-06 Impact factor: 79.321
Authors: Lisa Burry; Louise Rose; Iain J McCullagh; Dean A Fergusson; Niall D Ferguson; Sangeeta Mehta Journal: Cochrane Database Syst Rev Date: 2014-07-09
Authors: Amber E Barnato; Steven M Albert; Derek C Angus; Judith R Lave; Howard B Degenholtz Journal: Am J Respir Crit Care Med Date: 2010-11-05 Impact factor: 21.405
Authors: Andrés Esteban; Antonio Anzueto; Fernando Frutos; Inmaculada Alía; Laurent Brochard; Thomas E Stewart; Salvador Benito; Scott K Epstein; Carlos Apezteguía; Peter Nightingale; Alejandro C Arroliga; Martin J Tobin Journal: JAMA Date: 2002-01-16 Impact factor: 56.272
Authors: Mihaela S Stefan; Meng-Shiou Shieh; Penelope S Pekow; Nicholas Hill; Michael B Rothberg; Peter K Lindenauer Journal: Chest Date: 2015-04 Impact factor: 9.410
Authors: Timothy D Girard; John P Kress; Barry D Fuchs; Jason W W Thomason; William D Schweickert; Brenda T Pun; Darren B Taichman; Jan G Dunn; Anne S Pohlman; Paul A Kinniry; James C Jackson; Angelo E Canonico; Richard W Light; Ayumi K Shintani; Jennifer L Thompson; Sharon M Gordon; Jesse B Hall; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: Lancet Date: 2008-01-12 Impact factor: 79.321
Authors: Yahya Shehabi; Rinaldo Bellomo; Michael C Reade; Michael Bailey; Frances Bass; Belinda Howe; Colin McArthur; Ian M Seppelt; Steve Webb; Leonie Weisbrodt Journal: Am J Respir Crit Care Med Date: 2012-08-02 Impact factor: 21.405
Authors: Meeta Prasad Kerlin; Gary E Weissman; Katherine A Wonneberger; Saida Kent; Vanessa Madden; Vincent X Liu; Scott D Halpern Journal: Am J Respir Crit Care Med Date: 2016-12-15 Impact factor: 21.405
Authors: Anuj B Mehta; Allan J Walkey; Douglas Curran-Everett; Daniel Matlock; Ivor S Douglas Journal: Crit Care Med Date: 2019-03 Impact factor: 7.598
Authors: Meeta Prasad Kerlin; Andrew Epstein; Jeremy M Kahn; Theodore J Iwashyna; David A Asch; Michael O Harhay; Sarah J Ratcliffe; Scott D Halpern Journal: Ann Am Thorac Soc Date: 2018-03
Authors: Kei Ouchi; Guruprasad D Jambaulikar; Samuel Hohmann; Naomi R George; Emily L Aaronson; Rebecca Sudore; Mara A Schonberg; James A Tulsky; Jeremiah D Schuur; Daniel J Pallin Journal: J Am Geriatr Soc Date: 2018-03-15 Impact factor: 5.562